Since 2006, AABB has been a leader in the establishment of the US national hemovigilance program, from its beginning as a public-private collaboration for the program design to the implementation of a system to track adverse reactions and incidents associated with blood collection and transfusion. AABB has a role in recipient hemovigilance through the AABB Center for Patient Safety, a component Patient Safety Organization (PSO) of the AABB, the only nationally listed PSO dedicated to transfusion safety. Through collecting and analyzing adverse events in the context of transfusion, trends and best practices can be identified and interventions developed to significantly improve patient care and safety.
Revised TACO Definition for Comment before January 30, 2017
A revision of the ISBT/IHN definition for transfusion-associated circulatory overload (TACO) was launched in 2013. This draft explains the rationale for the revision and contains revised reporting criteria; it is publicly available on the ISBT, IHN and AABB websites for comment through the end of January 2017. Please direct your comments to Kevin Land, ISBT haemovigilance working party chair (firstname.lastname@example.org) or Jo Wiersum, TACO definition revision group (email@example.com) before 31st January 2017.
AABB coordinates multiple vigilance programs, including the West Nile Virus, Chagas Disease, and Zika Virus Biovigilance Networks and the AABB Blood Survey - a statistically validated survey of blood collection and utilization by the AABB membership.